Evidence map›Paper›PMID 22246860›Full record

ReviewAmerican journal of respiratory cell and molecular biology2012

Hypercapnia: a nonpermissive environment for the lung.

István Vadász, Rolf D Hubmayr, Nicolás Nin, Peter H S Sporn, Jacob I Sznajder

Abstract readReview
In one paragraph

Review in American journal of respiratory cell and molecular biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
5.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 83 citations in OpenAlex.

  1. Trial
  2. Hypercapnia Effects on Lung Function.Comprehensive Physiology · 2026
    Review
  3. The ribosomal landscape in influenza A virus infection: from molecular mechanisms to clinical relevance.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  4. Article
  5. Review
  6. Carbon dioxide regulatesInfection and immunity · 2025
    Article
  7. Article
  8. Hypercapnic acidosis affectsFrontiers in cellular and infection microbiology · 2025
    Article
  9. The role of extracorporeal COFrontiers in medicine · 2025
    Review
  10. Article
  11. Review
  12. Article
  13. Hypercapnia from Physiology to Practice.International journal of clinical practice · 2022
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Extracorporeal COSeminars in dialysis · 2021
    Article
  19. The use of extracorporeal COAnnals of intensive care · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 4 countries.

István VadászDepartment of Internal Medicine, University of Giessen Lung Center, Justus Liebig University, Germany. istvan.vadasz@innere.med.uni-giessen.de
Rolf D Hubmayr
Nicolás Nin
Peter H S Sporn
Jacob I Sznajder
Northwestern University · USHospital Universitario de Getafe · ESJustus-Liebig-Universität Gießen · DEMayo Clinic in Florida · US

Funding

MULTIDISCIPLINARY CLINICAL AND TRANSLATIONAL SCIENCE (MCTS) PROGRAM (UL1)UL1RR025741 · NCRR · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GREENLAND, PHILIP · 2008 to 2011
$24.7M
The injurious effects of hypercapnia on the alveolar epitheliumR01HL085534 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SZNAJDER, JACOB I · 2006 to 2018
$4.9M
Role and Regulation of Sodium, Potasium ATPase in LungR37HL048129 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SZNAJDER, JACOB I · 2008 to 2017
$4.0M
Genes Mediating Innate Immune Suppression by Hypercapnia in Mammals and FliesR01HL107629 · NHLBI · NORTHWESTERN UNIVERSITY · PI BEITEL, GREG J, SPORN, PETER H · 2012 to 2015
$1.5M
NCRR NIH HHS UL1 RR025741NHLBI NIH HHS HL-41829NHLBI NIH HHS HL-85534NHLBI NIH HHS R01 HL085534NHLBI NIH HHS R01 HL107629NHLBI NIH HHS R37 HL048129
6 · The paper itself

Abstract

Patients with severe acute and chronic lung diseases develop derangements in gas exchange that may result in increased levels of CO(2) (hypercapnia), the effects of which on human health are incompletely understood. It has been proposed that hypercapnia may have beneficial effects in patients with acute lung injury, and the concepts of "permissive" and even "therapeutic" hypercapnia have emerged. However, recent work suggests that CO(2) can act as a signaling molecule via pH-independent mechanisms, resulting in deleterious effects in the lung. Here we review recent research on how elevated CO(2) is sensed by cells in the lung and the potential harmful effects of hypercapnia on epithelial and endothelial barrier, lung edema clearance, innate immunity, and host defense. In view of these findings, we raise concerns about the potentially deleterious effects hypercapnia may have in patients with acute and chronic lung diseases.

Indexed as

Acute Lung InjuryCarbon DioxideCell MembraneHumansHypercapniaImmunity, InnateLungPulmonary AlveoliPulmonary EdemaRespiration, ArtificialCarbon Dioxide

Identifiers

PMID22246860
PMCPMC3359943
OpenAlexW2058319249

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.